CNBCLean R·
Pharma major plummets over 10% after third trial disappointment in a week
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Read at CNBC →
Business · 1 sources covering this
Pharma major plummets over 10% after third trial disappointment in a week
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/4f21b63dc08f9c4c126b034f2be8bad85b224639" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Pharma major plummets over 10% after third trial disappointment in a week"></iframe>
